LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China
- PMID: 19672984
- DOI: 10.1002/mds.22371
LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China
Abstract
Mutations in LRRK2, the gene that encodes leucine-rich repeat kinase 2 (LRRK2), are associated with autosomal dominant and sporadic forms of Parkinson's disease (PD) and are the most common genetic causes of PD. Recently, a R1628P variant has been reported as a risk factor for PD in Taiwan and Singapore. To determine the association of this variant and PD in the Han-Chinese population from mainland China, we analyzed its frequency in a cohort of 600 patients and 459 unrelated healthy controls. Forty (6.7%) patients were heterozygous and 3 (0.5%) homozygous for the R1628P variant, which was significantly more frequent than in the controls [2.4% heterozygous and 0.0% homozygous, Odds ratio = 3.14, 95%CI: 1.60-6.17, P < 0.01]. Considering the age at onset, this difference was found only in late-onset PD (older than 50) [Odds ratio = 3.76, 95% CI: 1.90-7.45, P < 0.01]. Our data confirms that the LRRK2 R1628P variant is associated with an increased risk to develop late onset PD in the ethnic Han-Chinese population.
Similar articles
-
LRRK2 Gly2385Arg variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China.Eur J Neurol. 2008 Mar;15(3):301-5. doi: 10.1111/j.1468-1331.2007.02052.x. Epub 2008 Jan 14. Eur J Neurol. 2008. PMID: 18201193
-
LRRK2 R1628P contributes to Parkinson's disease susceptibility in Chinese Han populations from mainland China.Brain Res. 2009 Nov 3;1296:113-6. doi: 10.1016/j.brainres.2009.08.047. Epub 2009 Aug 20. Brain Res. 2009. PMID: 19699188
-
Association of LRRK2 R1628P variant with Parkinson's disease in Ethnic Han-Chinese and subgroup population.Sci Rep. 2016 Nov 4;6:35171. doi: 10.1038/srep35171. Sci Rep. 2016. PMID: 27812003 Free PMC article.
-
Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease.Adv Neurobiol. 2017;14:3-30. doi: 10.1007/978-3-319-49969-7_1. Adv Neurobiol. 2017. PMID: 28353276 Review.
-
LRRK2 in Parkinson's disease: genetic and clinical studies from patients.FEBS J. 2009 Nov;276(22):6455-63. doi: 10.1111/j.1742-4658.2009.07344.x. Epub 2009 Oct 5. FEBS J. 2009. PMID: 19804413 Review.
Cited by
-
Effect of LRRK2 G2385R Variant on Subthalamic Deep Brain Stimulation Efficacy in Parkinson's Disease in a Han Chinese Population.Front Neurol. 2019 Nov 22;10:1231. doi: 10.3389/fneur.2019.01231. eCollection 2019. Front Neurol. 2019. PMID: 31824408 Free PMC article.
-
Relationship between LRRK2 R1628P polymorphism and Parkinson's disease in Asian populations.Oncotarget. 2016 Jul 26;7(30):46890-46898. doi: 10.18632/oncotarget.10378. Oncotarget. 2016. PMID: 27384489 Free PMC article.
-
Clinical Heterogeneity Among LRRK2 Variants in Parkinson's Disease: A Meta-Analysis.Front Aging Neurosci. 2018 Sep 19;10:283. doi: 10.3389/fnagi.2018.00283. eCollection 2018. Front Aging Neurosci. 2018. PMID: 30283330 Free PMC article.
-
Digesting the genetics of inflammatory bowel disease: insights from studies of autophagy risk genes.Inflamm Bowel Dis. 2012 Apr;18(4):782-92. doi: 10.1002/ibd.21868. Epub 2011 Sep 20. Inflamm Bowel Dis. 2012. PMID: 21936032 Free PMC article. Review.
-
Analysis on the susceptibility genes in two chinese pedigrees with familial Parkinson's disease.Neurol Res Int. 2010;2010:674740. doi: 10.1155/2010/674740. Epub 2010 Aug 23. Neurol Res Int. 2010. PMID: 21188226 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical